BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24011475)

  • 21. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W; Mattick D; Smith L
    Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
    Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
    Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
    Platt R; Coutu C; Meinert T; Roth JA
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of skin samples for bovine viral diarrhea virus by use of reverse transcriptase polymerase chain reaction assay after vaccination of cattle with a modified-live bovine viral diarrhea virus vaccine.
    Corbett EM; Grooms DL; Bolin SR
    Am J Vet Res; 2012 Feb; 73(2):319-24. PubMed ID: 22280397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of vaccines in preventing respiratory disease in beef calves after weaning.
    Weiblen R; Woods GT; Mansfield ME; Crandell RA
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):303-24. PubMed ID: 6280257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of viral vaccination of dairy heifer calves on the incidence of respiratory disease, mortality, and growth.
    Windeyer MC; Leslie KE; Godden SM; Hodgins DC; Lissemore KD; LeBlanc SJ
    J Dairy Sci; 2012 Nov; 95(11):6731-9. PubMed ID: 22959931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of infectious bovine rhinotracheitis virus immunization on viral shedding in challenge-exposed calves treated with dexamethasone.
    Rossi CR; Kiesel GK
    Am J Vet Res; 1982 Sep; 43(9):1576-9. PubMed ID: 6293350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
    Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
    Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of infectious bovine rhinotracheitis and bovine viral diarrhea virus type 1 and type 2 in non-vaccinated cattle herds in the Pacific Region of Central Costa Rica.
    Raizman EA; Pogranichniy R; Negron M; Schnur M; Tobar-Lopez DE
    Trop Anim Health Prod; 2011 Apr; 43(4):773-8. PubMed ID: 21128116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroconversion to bovine viral diarrhoea virus and infectious bovine rhinotracheitis virus in dairy herds of Michoacan, Mexico.
    Segura-Correa JC; Solorio-Rivera JL; Sánchez-Gil LG
    Trop Anim Health Prod; 2010 Feb; 42(2):233-8. PubMed ID: 19685278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
    Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age at the time of vaccination on antibody titers and feedlot performance in beef calves.
    Kirkpatrick JG; Step DL; Payton ME; Richards JB; McTague LF; Saliki JT; Confer AW; Cook BJ; Ingram SH; Wright JC
    J Am Vet Med Assoc; 2008 Jul; 233(1):136-42. PubMed ID: 18593324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
    Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
    BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.